STKE 2007, 2007:4. 3. Pedras-Vasconcelos J, Puig M, Verthelyi D: TLRs as therapeutic targets in CNS inflammation and infection. Front Biosci (Elite Ed) 2009, 1:476?87. four. Carty M, Bowie AG: Evaluating the function of Toll-like receptors in illnesses from the central nervous technique. Biochem Pharmacol 2011, 81:825?37. five. Hanisch UK, Johnson Tv, Kipnis J: Toll-like receptors: roles in neuroprotection? Trends Neurosci 2008, 31:176?82. 6. Babcock AA, Wirenfeldt M, Holm T, Nielsen HH, Dissing-Olesen L, ToftHansen H, Millward JM, Landmann R, Rivest S, Finsen B, Owens T: Toll-like receptor 2 signaling in response to brain injury: an innate bridge to neuroinflammation. J Neurosci 2006, 26:12826?2837. 7. Mao SS, Hua R, Zhao XP, Qin X, Sun ZQ, Zhang Y, Wu YQ, Jia MX, Cao JL, Zhang YM: Exogenous administration of PACAP alleviates traumatic brain injury in rats through a mechanism involving the TLR4/MyD88/NF-B pathway. J Neurotrauma 2012, 29:1941?959. eight. Zhang Z, Zhang ZY, Wu Y, Schluesener HJ: Immunolocalization of Toll-like receptors two and four also as their endogenous ligand, heat shock protein 70, in rat traumatic brain injury.1160614-73-2 Data Sheet Neuroimmunomodulation 2012, 19:ten?9.5-Chloro-3-methyl-1H-pyrazole web 9.PMID:23453497 Ziegler G, Prinz V, Albrecht MW, Harhausen D, Khojasteh U, Nacken W, Endres M, Dirnagl U, Nietfeld W, Trendelenburg G: Mrp-8 and -14 mediate CNS injury in focal cerebral ischemia. Biochim Biophys Acta 2009, 1792:1198?204. 10. Zhou ML, Shi JX, Hang CH, Zhang FF, Gao J, Yin HX: Expression of Toll-like receptor 4 within the brain inside a rabbit experimental subarachnoid haemorrhage model. Inflamm Res 2007, 56:93?7. 11. Sansing LH, Harris TH, Welsh FA, Kasner SE, Hunter CA, Kariko K: Toll-like receptor 4 contributes to poor outcome following intracerebral hemorrhage. Ann Neurol 2011, 70:646?56. 12. Lin S, Yin Q, Zhong Q, Lv FL, Zhou Y, Li JQ, Wang JZ, Su BY, Yang QW: Heme activates TLR4-mediated inflammatory injury by means of MyD88/TRIF signaling pathway in intracerebral hemorrhage. J Neuroinflammation 2012, 9:46. 13. Filli L, Schwab ME: The rocky road to translation in spinal cord repair. Ann Neurol 2012, 72:491?01. 14. Yao AH, Jia LY, Zhang YK, Ma QR, Cheng P, Liu L, Ju G, Kuang F: Early blockade of TLRs MyD88-dependent pathway may reduce secondary16.17. 18.19.20.21.22.23.24.25.26.27.28. 29.30.31.32. 33.34.35. 36. 37.spinal cord injury in the rats. Evid Primarily based Complement Alternat Med 2012, 2012:591298. Mautes AE, Weinzierl MR, Donovan F, Noble LJ: Vascular events soon after spinal cord injury: contribution to secondary pathogenesis. Phys Ther 2000, 80:673?87. Tator CH, Fehlings MG: Assessment of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 1991, 75:15?six. Oyinbo CA: Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade. Acta Neurobiol Exp 2011, 71:281?99. Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, McCrea E, Shapiro A, Antel JP: TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 2005, 175:4320?330. Griffiths MR, Gasque P, Neal JW: The regulation of your CNS innate immune response is very important for the restoration of tissue homeostasis (repair) soon after acute brain injury: a short evaluation. Int J Inflam 2010, 2010:151097. Jia LY, Yao AH, Kuang F, Zhang YK, Shen XF, Ju G: Valuable impact from the traditional chinese drug shu-xue-tong on recovery of spinal cord injury within the rat. Evid Based Complement Alternat Med 2011, 2011:862197. Noble LJ, Wrathall JR: The blood-spinal cord barrier.